This inventor holds 1 USPTO granted patent. Top assignee: Japan Breast Cancer Research Group. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Innovations in Cancer Treatment: The Contributions of Norikazu Masuda
Introduction
Norikazu Masuda, an accomplished inventor from Osaka, Japan, has made significant strides in the field of oncology. With a focus on improving the administration methods of anti-cancer drugs, Masuda's work aims to enhance treatment outcomes for patients diagnosed with breast cancer. His contributions have not only advanced medical knowledge but also provided practical solutions for the complexities involved in personalized cancer treatment.
Latest Patents
Masuda holds a patent for a unique method for the administration of anti-cancer drugs. This innovative methodology is designed to determine the specific type of cancer based on hormonal receptor status, which includes both estrogen receptor (ER) and human epidermal growth factor receptor 2 (Her2) characteristics. The patent outlines a systematic approach where the treatment protocol varies depending on the receptor status, optimizing the sequence of drug administration for improved efficacy.
Career Highlights
Currently, Norikazu Masuda is associated with the Japan Breast Cancer Research Group, where his expertise plays a pivotal role in ongoing research and treatment development. His focus on individualized treatment plans showcases his dedication to advancing patient care and enhancing the effectiveness of cancer therapies.
Collaborations
Throughout his career, Masuda has collaborated with notable colleagues, including Masakazu Toi and Hiroji Iwata. These partnerships foster a multidisciplinary approach to cancer research, empowering teams to tackle complex challenges and drive innovations that can lead to breakthroughs in treatment options.
Conclusion
Norikazu Masuda's contributions to the field of cancer treatment reflect a commitment to improving the lives of patients facing breast cancer. His innovative patent for the administration of anti-cancer drugs represents a significant step forward in personalized medicine. As research continues to evolve, Masuda's work serves as an inspiration for future inventors and researchers dedicated to combating cancer through tailored therapeutic strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile